Mark Rothera

CIK 1550424 · President and CEO · last filed 2024-03-13

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.23M

Companies

3

Total Filings

28

Lifetime Open-Market Net

-$4.67M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Viracta Therapeutics, Inc. (VIRX) Delisted President and CEO 52,094 $0.01 $511 $49.4K 4 2024-03-13
PTCT Chief Commercial Officer 42,955 $75.14 $3.23M -$4.72M 23 2017-05-25
Aegerion Pharmaceuticals, Inc. (AEGR) Delisted Global President $0 1 2012-06-05

Recent Filings · Page 2 of 3

28 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-10-11 PTCT Exer (M) +1,950 $21.2K EDGAR
2016-09-26 PTCT Exer (M) +2,200 $23.9K EDGAR
2016-03-07 PTCT Buy (P) +2,000 $12.5K EDGAR
2016-01-15 PTCT Exer (M) +3,125 $33.9K EDGAR
2016-01-06 PTCT Grant (A) $0 EDGAR
2015-07-21 PTCT Exer (M) +9,216 $100.0K EDGAR
2015-03-18 PTCT Mixed -$704.0K EDGAR
2015-03-13 PTCT Mixed -$19.7K EDGAR
2015-02-25 PTCT Mixed −3,000 -$2.03M EDGAR
2015-01-22 PTCT Sell (S) −3,000 -$180.1K EDGAR
Showing 1120 of 28
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.